OLE: Biohaven Rise 2
Brief description of study
Open label extension of RISE, a study of BHV7000 in patients 18+ with focal epilepsy.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Medical Research
-
Age:
99 years or below
-
Gender: All
Updated on
14 Nov 2024.
Study ID: 24-1444